Samplix's Xdrop® technology is a proprietary droplet-based platform designed for single-molecule encapsulation.
Samplix has raised $8.2M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in March 2023.
Samplix's investors include European Innovation Council, EISMEA, Fjord Capital.
Samplix is headquartered in Herlev, Denmark.
Samplix's Xdrop® technology is a proprietary droplet-based platform designed for single-molecule encapsulation.
Samplix is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Samplix — Funding & Investors." VCBacked, March 30, 2023, https://www.vcbacked.co/company/samplix. Accessed September 30, 2026.
VCBacked. (2023). Samplix — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/samplix
{{cite web |title=Samplix — Funding & Investors |url=https://www.vcbacked.co/company/samplix |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated